ICU Stock Analysis: Buy, Sell, or Hold?
ICU - SeaStar Medical Holding Corporation Common Stock
$2.38
0.04 (1.93%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 26, 2026
Get Alerted When ICU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ICU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ICU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ICU is currently trading at $2.38, which is considered fair relative to its 30-day fair value range of $0.98 to $2.91.
Technical Outlook: Technically, ICU is in a uptrend. Immediate support is located at $2.26, while resistance sits at $2.71.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+362.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ICU is in a uptrend. Immediate support is located at $2.26, while resistance sits at $2.71.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+362.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.98 -
$2.91
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 362.2% below Wall St target ($11.00)
- CAUTION: Recommendation downgraded due to -7.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.98 -
$2.91
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$2.26
Resistance Level
$2.71
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.73
Wall Street Target
$11.00
(+362.2%)
Revenue Growth (YoY)
169.1%
Last updated: February 01, 2026 5:20 PM ET
Data refreshes hourly during market hours. Next update: 6:20 PM
Data refreshes hourly during market hours. Next update: 6:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICU showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Heel Kenneth Van
BUY
10000 shares
2025-08-27
Heel Kenneth Van
BUY
25000 shares
2025-08-26
Kevin Chung
BUY
10000 shares
2025-08-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 59 HOLD |
